Intermediate Bone Neoplasm — Trials

Intermediate Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03301857	Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004	completed	Phase 4	85	AmgenINDUSTRY	8	May 20, 2024	clinicaltrials
NCT00396279	Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone	completed	Phase 2	37	AmgenINDUSTRY	0	Nov 8, 2022	clinicaltrials
NCT00680992	Study of Denosumab in Subjects With Giant Cell Tumor of Bone	completed	Phase 2	535	AmgenINDUSTRY	12	Sep 22, 2022	clinicaltrials
NCT05402865	A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone	completed

Data updated 22 days agoSource updated May 20, 2024source: clinicaltrials